Cipla launches remdesivir, claims it is inexpensive

Claimed to be priced the lowest in the market, the product is launched under a licensing agreement with the US-based Gilead Sciences Inc.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...